
    
      Gemcitabine and Oxaliplatin(GemOx) shows effective activity in patients with relapsed diffuse
      large-cell lymphoma and other solid tumors. The purpose of this study is to investigate
      efficacy and safety of Lenalidomide in combination with R-GemOx as first-line treatment of
      elderly patients with Diffuse large B cell lymphoma.
    
  